Sold as Lorelco. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Probucol (sold as Lorelco), first approved Feb 1, 1977, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Feb 1, 1977 | LorelcoNDA 17535 ยท New molecular entity | Sanofi Aventis US | 20 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
